Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
Clinical trial NCT04215731 · RECRUITING
Trial details
- NCT number
- NCT04215731
- Sponsor
- Yanhong Deng
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-27
- Primary completion
- 2026-09-01
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.